UCM Ventures
Overview
UCM Ventures is a strategic venture investment vehicle of UChicago Medicine that invests in growth-stage healthcare companies developing transformative technologies.
Portfolio Companies
7
Website
uchicagomedicine.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ultromics | Jul 2025 | Series C | Co-investor |
| KeyCare | Mar 2026 | Early Funding | Co-investor |
| G LNK | - | Seed | Co-investor |
| MyMenopauseRx | Dec 2022 | Accelerator | Co-investor |
| Parasol Med Tech, Inc. | Oct 2026 | Seed Round | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is UCM Ventures based?
UCM Ventures is headquartered in Chicago, Illinois, United States.
When was UCM Ventures founded?
Founding year information for UCM Ventures is not publicly available.
How many portfolio companies does UCM Ventures have?
UCM Ventures has 7 portfolio companies in Caplight's dataset.
What are some companies in UCM Ventures's portfolio?
Portfolio companies visible on Caplight include Ultromics, KeyCare, G LNK, MyMenopauseRx, Parasol Med Tech, Inc..
What was UCM Ventures's most recent investment shown here?
UCM Ventures's most recent investment in this portfolio sample was in Parasol Med Tech, Inc. in 2026.
What sectors does UCM Ventures focus on?
UCM Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does UCM Ventures focus on?
UCM Ventures typically invests at the Early stage.